Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Stanford Experts on Method of Deriving Embryonic Stem Cells

Published: Thursday, August 24, 2006
Last Updated: Thursday, August 24, 2006
Bookmark and Share
In the method single removed cell can divide to produce a line of normal embryonic stem cells.

Stem cell experts at the Stanford University School of Medicine cited several concerns regarding a newly published method of generating human embryonic stem cells without destroying the embryo.

Scientists at Advanced Cell Technologies published their method in the Aug. 24 issue of the journal Nature.

Current methods of generating embryonic stem cells involve removing the cells from a roughly 5-day-old embryo, destroying the embryo in the process.

Because of moral concerns about the destruction of an embryo, President George W. Bush has refused federal funding for the creation of new stem cell lines.

The method draws on a technique called pre-implantation genetic diagnostics, or PGD, used by in-vitro fertility clinics to check for genetic defects in the embryo.

In this technique, one of the embryo's eight cells is removed; the remaining cells are able to grow into a viable embryo for implantation and might therefore overcome the administration's restrictions on funding.

According to the Nature paper, the single removed cell can divide to produce a line of normal embryonic stem cells.

Following are comments from four Stanford stem cell experts on the scientific, ethical and political merits of this new technique:

Hank Greely, JD, professor of law and chair of the Stanford Center for Biomedical Ethics steering committee, "From the scientific perspective, never believe anything until it's replicated several times."

"That's not an accusation of fraud, but science is full of honestly nonreplicable findings. It has to be able to be replicated reliably."

"Second, speaking still about the science, it will be interesting and important to see if these cells turn out to be the same kind of cells with the same kind of promise as stem cells derived from blastocysts."

"On the ethics side, first it needs to be determined whether these cells can actually be done with embryos subject to pre-implantation genetic diagnosis without jeopardizing the viability of those embryos."

"This paper does not speak to that at all. They did not use PGD, though the authors say that is the way it should be done."

"The second ethics point is that some of the people who oppose research on embryos won't view this as protecting an embryo, but as turning it into two embryos and killing the second."

"It will be interesting to see how much of the embryo-rights movement's opposition might be weakened by this."

"And my one political point: I don't know what the White House will do. It might provide President Bush with a face-saving and politically helpful compromise, even if it doesn't satisfy all of the opponents of embryonic stem cell research."

Irving Weissman, MD, director of the Stanford Institute for Stem Cell Biology and Regenerative Medicine: After talking with Weissman about the study, New York Times science reporter Nicholas Wade wrote, "Scientists welcomed the new development, but also expressed concerns."

"Dr. Irving Weissman, a stem cell expert at Stanford University, said the new method, if confined to PGD-derived blastomeres, would not provide a highly desired type of cell, those derived from patients with a specific disease."

Weissman's concern is that the newly created stem cell lines would mirror the genetic background of people undergoing IVF.

He hopes to see stem cell lines from people with genetic disorders, such as diabetes, cystic fibrosis or Parkinson's disease.

Creating stem cells from the cells of people with those diseases would allow researchers to study how the disease develops and how the cells respond to drug treatments.

David Magnus, PhD, director of the Stanford Center for Biomedical Ethics, "While the work by Advanced Cell Technologies is very interesting and might be a potentially interesting additional way of procuring and developing embryonic stem cells, it is deeply misguided to think of this as a solution to the ethical controversy over human embryonic stem cell research."

"First, it is unlikely that all (and perhaps not even most) opponents of embryonic stem cell research will agree that this eliminates their ethical objections."

"To use the techniques discussed, there must be a commitment to accepting in-vitro fertilization and PGD - but since this results in the creation and destruction of embryos, most opponents of embryonic stem cell research will object to this as well."

"In addition, while it is unlikely that the separated blastomeres have the capacity to develop into humans, it has not been shown to be impossible. For many of the opponents of embryonic stem cell research, that distinction matters."

"Otherwise, the opponents would accept somatic cell nuclear transfer (another experimental method of creating stem cells) using adult somatic cells, since it is unlikely that any of these can ever develop into a human."

"Second, and most importantly, the idea of trying to find a consensus is deeply flawed."

"The principle that there should not be research that some individuals oppose would lead us to abandon all evolutionary and population genetics research (since creationists oppose it), research on animals (many oppose all research on animals) and possibly all research (since there are people who oppose most biotechnology)."

"Attempting to find a 'common ground' is really a strategy designed to provide political cover to those who oppose embryonic stem cell research (an unpopular position)."

"It is as likely to succeed as trying to find an abortion method that right to life groups will find morally acceptable."

Christopher Thomas Scott, executive director of the Stanford Program on Stem Cells in Society, which is part of the biomedical ethics center, "In terms of the science, it's an important result because it breaks the species barrier."

"In cell biology, going from animal models to primates models is difficult, so when you successfully replicate a result from animals in humans, that's a big result."

"Advanced Cell Technologies has transferred the result from an animal model to a primate model - that in itself is enough to take notice."

"From the moral perspective, it solves a few problems, but not the big one - notably the objection of those people who believe that the embryo has rights and is a human being and that experimenting on an embryo that cannot give its consent is using the embryo as a means to an end."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Tiny Spheres Of Human Cells Mimic The Brain
Researchers have figured out how to create spheres of neuronal cells resembling the cerebral cortex, making functional human brain tissue available for the first time to study neuropsychiatric diseases such as autism and schizophrenia.
Wednesday, May 27, 2015
Telomere Extension Turns Back Aging Clock In Cultured Cells
Researchers delivered a modified RNA that encodes a telomere-extending protein to cultured human cells. Cell proliferation capacity was dramatically increased, yielding large numbers of cells for study.
Tuesday, January 27, 2015
Stem Cells Faulty In Duchenne Muscular Dystrophy
In a mouse model of Duchenne muscular dystrophy, muscle stem cells express connective-tissue genes associated with fibrosis and muscle weakness, according to a new study.
Thursday, December 18, 2014
Tumor Suppressor Also Inhibits Key Property Of Stem Cells
The retinoblastoma protein inhibits cancer by controlling cell division. Now, researchers have shown that it also binds to and inhibits genes necessary for pluripotency.
Friday, November 14, 2014
Scientists Discern Signatures of Old Versus Young Stem Cells
A chemical code scrawled on histones determines which genes in that cell are turned on and which are turned off.
Wednesday, July 03, 2013
New Method Allows Human Embryonic Stem Cells to Avoid Immune System Rejection, Study Finds
According to Stanford University researchers, a short-term treatment with three immune-dampening drugs allowed human embryonic stem cells to survive and thrive in mice.
Wednesday, March 09, 2011
$33M Donation will Fund Stem Cell Building at Stanford
Lorry I. Lokey, the founder of Business Wire will give $33 million to help build new laboratories for Stanford’s Institute for Stem Cell Biology and Regenerative Medicine.
Wednesday, March 07, 2007
Researchers Advance in bid to Turn Mice Stem Cells into Blood Vessels
The goal of the research is to bring together two areas of medical investigation: stem cell research and tissue engineering.
Tuesday, June 27, 2006
Scientific News
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!